US 6693202
Muscarinic receptor antagonists
expired A61KA61K31/40
Quick answer
US patent 6693202 (Muscarinic receptor antagonists) held by Theravance, Inc. expires Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Feb 17 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/40